PT Pyridam Farma Tbk (ISX:PYFA) Forward Dividend Yield %: 0.00% (As of Jul. 02, 2026)


ISX:PYFA PT Pyridam Farma Tbk ISX:PYFA
66 GF Score
Price Rp198.00
GF Value Rp212.72
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PT Pyridam Farma Tbk Forward Dividend Yield %?

PT Pyridam Farma Tbk ISX:PYFA +6.45% 66 Forward Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus rates ISX:PYFA with a GF Score™ of 66/100 and a GF Value™ of Rp212.72 (Fairly Valued). The stock has 8 warning signs investors should review. Among 506 Drug Manufacturers companies, PT Pyridam Farma Tbk ranks worse than 197628.26% on this metric.

As of today (2026-07-02), the Forward Annual Dividend Yield of PT Pyridam Farma Tbk is 0.00%.

As of today (2026-07-02), the Trailing Annual Dividend Yield of PT Pyridam Farma Tbk is 0.00%.

ISX:PYFA's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.085
* Ranked among companies with meaningful Forward Dividend Yield % only.

PT Pyridam Farma Tbk's Dividends per Share for the three months ended in Mar. 2026 was Rp0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


PT Pyridam Farma Tbk  (ISX:PYFA) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


PT Pyridam Farma Tbk Forward Dividend Yield % Related Terms


ISX:PYFA vs ZTS, UTHR, VTRS: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PT Pyridam Farma Tbk's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Pyridam Farma Tbk Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Pyridam Farma Tbk's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where PT Pyridam Farma Tbk's Forward Dividend Yield % falls into.


ISX:PYFA
66GF Score
PT Pyridam Farma Tbk ISX:PYFA
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Pyridam Farma Tbk Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
PT Pyridam Farma Tbk (ISX:PYFA) has a Forward Dividend Yield % of 0.00% as of Jul. 02, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on PT Pyridam Farma Tbk and its competitors. According to the industry distribution chart, PT Pyridam Farma Tbk ranks #999999 out of 506 companies in the Drug Manufacturers industry.
Is PT Pyridam Farma Tbk's Forward Dividend Yield % too high?
PT Pyridam Farma Tbk's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, PT Pyridam Farma Tbk ranks #999999 out of 506 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PT Pyridam Farma Tbk has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Pyridam Farma Tbk's Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Pyridam Farma Tbk ranks #999999 out of 506 companies for Forward Dividend Yield %. This places PT Pyridam Farma Tbk in the lower half of its industry. The industry median Forward Dividend Yield % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.09, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on PT Pyridam Farma Tbk and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Pyridam Farma Tbk's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Pyridam Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk (ISX:PYFA) is currently considered Fairly Valued. The stock's GF Value™ is Rp212.72, compared to a current price of Rp198.00 — trading 6.9% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. PT Pyridam Farma Tbk's overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For PT Pyridam Farma Tbk (ISX:PYFA), the current Forward Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Pyridam Farma Tbk (ISX:PYFA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Pyridam Farma Tbk stock appears to be undervalued. The current stock price of Rp198.00 is trading 6.9% below its estimated GF Value™ of Rp212.72. GuruFocus considers PT Pyridam Farma Tbk to be Fairly Valued.

Key valuation signals for ISX:PYFA:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: Rp212.72 vs. price of Rp198.00 (6.9% below fair value)
  • GF Score™: 66/100 with 8 warning signs

No single metric tells the full story. See the ISX:PYFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Pyridam Farma Tbk Business Description

Address Jl. Jenderal Sudirman Kav. 21, Sinar Mas Land Plaza Sudirman 12th Floor, RT 10/RW 01 Kuningan, Karet, Jakarta Selatan, Jakarta, IDN, 12920
PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical products, Esthetics, and Toll manufacturing services; and Medical equipment Products segment. The company derives maximum revenue from Pharmaceutical products, Esthetics, and Toll manufacturing services. The company's products include consumer health, Derma, prescription, and biomedilab.
66GF Score

Get the complete analysis for ISX:PYFA

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp198.00
Price
Rp212.72
GF Value